Seizure Detection and Warning System for Epilepsy Patients
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
1 other identifier
observational
239
1 country
1
Brief Summary
The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2013
CompletedFirst Posted
Study publicly available on registry
June 11, 2013
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJuly 10, 2019
July 1, 2019
6.4 years
June 5, 2013
July 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.
The primary objective of the research is to determine the ability of the Brain Sentinel Seizure Detection System to accurately detect GTC seizures in comparison to the recognized "gold standard" for seizure detection, video Electroencephalography (vEEG).The primary endpoint will be the sensitivity of GTC seizure detection (defined as within 30 seconds of motor manifestation via vEEG analysis) in a hospital setting.
less than 1 month
Secondary Outcomes (1)
Comparison of study device to self reporting of seizures using a seizure diary.
Less than 1 month
Study Arms (1)
Epilepsy Patients
This study will compare accuracy of seizure detection by the study device to simultaneously collected data of seizure detection by video EEG.
Interventions
The Brain Sentinel Seizure Detection Device and Warning System is designed to monitor Epilepsy patients and alerts caregivers that a GTC seizure is occurring
Eligibility Criteria
Adolescent epilepsy patients with a history of generalized tonic-clonic seizures either primary GTC or partial onset seizures with second generalization.
You may qualify if:
- Subject has a suspected history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization.
- Is being admitted to a hospital for routine vEEG monitoring related to seizures.
- Male or female between the ages of 13-21.
- If female and of childbearing potential, has a negative pregnancy urine test, and must also not be nursing.
- Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
- Subject and/or Primary Caregiver must be competent to follow all study procedures.
- Is able to read, speak, and understand English or has a LAR that does so.
- Subject/LAR consents to the use of vEEG files, including video/audio recordings, for purposes of this research study.
You may not qualify if:
- Has not had a GTC seizure within the last year AND is not expected to have a reduction of anti-epileptic drugs during their hospital admission.
- Intracranial EEG electrodes are being used.
- The subject is allergic to adhesives or any component of the electrode patch assembly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brain Sentinellead
Study Sites (1)
Brain Sentinel
San Antonio, Texas, 78232-1399, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose' E Cavazos, MD, PhD
Brain Sentinel
- PRINCIPAL INVESTIGATOR
Dennis Dlugos, MD
Children's Hospital of Philadelphia
- PRINCIPAL INVESTIGATOR
Jonathan Halford, MD
Medical University of South Carolina
- PRINCIPAL INVESTIGATOR
Dileep Nair, MD
The Cleveland Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2013
First Posted
June 11, 2013
Study Start
July 1, 2013
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
July 10, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share